Biological E acquires Akorn India to ramp up vaccine & injectable medicine capacities

Biological E acquires Akorn India to ramp up vaccine & injectable medicine capacities Akorn India, a subsidiary of the US-based Akorn Inc., has a manufacturing plant of 39,000 square metres over a 14-acre campus in Himachal Pradesh with an annual capacity for about 135 million units. BE said the Akorn India facility has the potential for immediate expansion of a further 30 million units. https://ift.tt/eA8V8J